Brain scans could predict best Quit-Smoking drug
NCT ID NCT02162849
Summary
This study aims to find out if one of two FDA-approved quit-smoking medications works better for people based on their brain activity and how they process emotions. About 200 adult smokers will receive counseling and be randomly assigned to take either varenicline (Chantix) or use a nicotine patch. Researchers will use brain scans and questionnaires to see if a person's traits help predict which treatment helps them quit for good.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOBACCO USE CESSATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.